Calamos Advisors’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.78M | Buy |
537,320
+3,483
| +0.7% | +$63.4K | 0.04% | 397 |
|
|
2025
Q1 | $10.6M | Buy |
533,837
+107,931
| +25% | +$2.14M | 0.05% | 361 |
|
|
2024
Q4 | $7.3M | Buy |
425,906
+28,154
| +7% | +$483K | 0.03% | 437 |
|
|
2024
Q3 | $7.95M | Sell |
397,752
-205,251
| -34% | -$4.1M | 0.03% | 440 |
|
|
2024
Q2 | $6.74M | Buy |
603,003
+46,405
| +8% | +$519K | 0.03% | 450 |
|
|
2024
Q1 | $3.67M | Buy |
556,598
+306,413
| +122% | +$2.02M | 0.02% | 513 |
|
|
2023
Q4 | $1.13M | Buy |
250,185
+137,749
| +123% | +$623K | 0.01% | 622 |
|
|
2023
Q3 | $403K | Buy |
112,436
+55,212
| +96% | +$198K | ﹤0.01% | 687 |
|
|
2023
Q2 | $211K | Buy |
+57,224
| New | +$211K | ﹤0.01% | 753 |
|